Axsome Therapeutics Inc Sustainability Reports
Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company that develops and commercializes novel therapies for central nervous system disorders.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300EXGR0XLRJEIB95
FIGI: BBG00B6G7GM6
3 reports from 2022 to 2025
